DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 376 participants.

Also called NCT03643224

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 376 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03643224
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, Czechia, France, Germany, Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03643224. Allocation not applicable; no masking; primary purpose treatment. Start 2018-09-19 (actual); primary completion 2024-10-31 (actual). Results posted on 2025-10-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation
Acronym
Diamond-AFII
Condition
Persistent Atrial Fibrillation
Condition
Atrial Fibrillation
Intervention (Device)
Radiofrequency Ablation
Lead sponsor
Medtronic Cardiac Ablation Solutions (class: industry)

Record details

Record id
cardio:ct-nct03643224
Content hash
437d48fec336c23f8c48028f2a29b8e9e0e35bcc0d1f7ba5a064f2ba8f614289